Top Stocks
Dividend Investing
ETFs
Stock Comparison
About Us
Working with TipRanks
Follow Us
Acurx Pharmaceuticals (ACXP)
NASDAQ:ACXP
Acurx Pharmaceuticals (ACXP) Stock Price & Analysis
22 Followers
ACXP Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$2.33 - $4.85
Previous Close$3.4
Volume7.99K
Average Volume (3M)34.75K
Market Cap
$42.64M
Enterprise Value$32.54M
Total Cash (Recent Filing)$9.11M
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)-3.0
Beta0.51
Next Earnings
May 10, 2023EPS Estimate
-$0.24Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.11
Shares Outstanding11,635,795
10 Day Avg. Volume27,123
30 Day Avg. Volume34,752
Standard Deviation0.15
R-Squared0.14
Alpha-0.02
Financial Highlights & Ratios
Price to Book (P/B)5.63
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio-5.50
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit10.00T>
Enterprise Value/Ebitda-2.69
Forecast
1Y Price Target
$13.00Price Target Upside273.56% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
Acurx Pharmaceuticals News
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Product Monthly Users
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
ACXP FAQ
What was Acurx Pharmaceuticals’s price range in the past 12 months?
Acurx Pharmaceuticals lowest stock price was $2.33 and its highest was $4.85 in the past 12 months.
What is Acurx Pharmaceuticals’s market cap?
Currently, no data Available
When is Acurx Pharmaceuticals’s upcoming earnings report date?
Acurx Pharmaceuticals’s upcoming earnings report date is May 10, 2023 which is in 42 days.
How were Acurx Pharmaceuticals’s earnings last quarter?
Acurx Pharmaceuticals released its earnings results on Mar 16, 2023. The company reported -$0.28 earnings per share for the quarter, beating the consensus estimate of -$0.29 by $0.01.
Is Acurx Pharmaceuticals overvalued?
According to Wall Street analysts Acurx Pharmaceuticals’s price is currently Undervalued.
Does Acurx Pharmaceuticals pay dividends?
Acurx Pharmaceuticals does not currently pay dividends.
What is Acurx Pharmaceuticals’s EPS estimate?
Acurx Pharmaceuticals’s EPS estimate is -$0.24.
How many shares outstanding does Acurx Pharmaceuticals have?
Acurx Pharmaceuticals has 11,635,795 shares outstanding.
What happened to Acurx Pharmaceuticals’s price movement after its last earnings report?
Acurx Pharmaceuticals reported an EPS of -$0.28 in its last earnings report, beating expectations of -$0.29. Following the earnings report the stock price went down -1.466%.
Which hedge fund is a major shareholder of Acurx Pharmaceuticals?
Currently, no hedge funds are holding shares in ACXP
---
Acurx Pharmaceuticals Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$13.00 (273.56% Upside)
$13.00 (273.56% Upside)
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
9.32%
12-Months-Change
Fundamentals
Return on Equity
-122.61%
Trailing 12-Months
Asset Growth
-29.25%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Acurx Pharmaceuticals
Acurx Pharmaceuticals Inc is a clinical stage biopharmaceutical company developing a new class of antibiotics for infections caused by bacteria listed as priority pathogens by the World Health Organization, Centers for Disease Control and Prevention, and Food and Drug Administration.
---
Top 5 ETFs holding ACXP
Currently, no data available
Please return soon. This page is being updated.
Up to five ETFs with an Outperform Smart Score that hold ACXP. The ETFs are listed according to market value of ACXP within the ETF
---
IN8bio
―
NextCure
―
Cyclerion Therapeutics
―
Gain Therapeutics
―
Applied Molecular Transport
―
---